ArticleBMC pulmonary medicine2026
Incidence and outcomes of patients hospitalised with COPD in Greater Glasgow and Clyde, Scotland 2015-2022: a retrospective cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundChronic Obstructive Pulmonary Disease (COPD) significantly impacts patients' quality of life and healthcare systems, especially among socio-economically deprived populations. Hospitalisations due to COPD exacerbations are critical events, often indicating declining health and higher mortality risk. This study examines the incidence and outcomes of COPD hospitalisations in National Health Service (NHS) Greater Glasgow and Clyde from 2015 to 2022, with a focus on socio-economic inequalities and the effects of the COVID-19 pandemic on hospitalisation trends.
methodsWe conducted a retrospective cohort study using routinely collected hospital episode data, linked to mortality records, for a population of 1.2 million. Incident COPD hospitalisations were identified via International Classification of Diseases version 10 (ICD-10) codes, with no prior hospital admission in the preceding three years. Recurrent hospitalisations were those occurring within 3 years of the discharge of an incident event. We employed negative binomial regression to analyse hospital admission rates and Cox regression for time to recurrent hospitalisation and mortality outcomes, adjusting for demographic and comorbidity factors and testing for interactions with socio-economic status. Before getting the study sample, data linkage was done by the oGRE analyst team.
resultsFrom 2015-2022, 8,852 incident COPD hospitalisations were recorded. The mean patient age was 70 years, and 61% were female. Incident hospitalisation rates declined by 13-48% from 2017 onwards. Mortality following incident hospital admission increased post-2020 (HR for 2022 vs. 2015 = 1.42, 95% CI 1.19-1.71). Recurrent hospitalisation rates declined significantly over the study period. Socio-economic inequalities were prominent, with the most deprived individuals experiencing higher hospitalisation and mortality rates.
conclusionOur study highlights a reduction in COPD hospitalisations and recurrent admissions in recent years, potentially due to enhanced disease management strategies and pandemic-related healthcare changes. However, increased mortality post-hospitalisation and persistent socio-economic inequalities underscore the need for targeted interventions. Addressing these inequities through innovative care models and community-based support remains crucial to improving outcomes for patients with COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.